0001698655-17-000001.txt : 20170222 0001698655-17-000001.hdr.sgml : 20170222 20170222150511 ACCESSION NUMBER: 0001698655-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170222 DATE AS OF CHANGE: 20170222 EFFECTIVENESS DATE: 20170222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jecure Therapeutics, Inc. CENTRAL INDEX KEY: 0001698655 IRS NUMBER: 811341025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281127 FILM NUMBER: 17628025 BUSINESS ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-750-0045 MAIL ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0707 D LIVE 0001698655 Jecure Therapeutics, Inc. 3210 MERRYFIELD ROW SAN DIEGO CA CALIFORNIA 92121 858-750-0045 DELAWARE None None Corporation true 2015 Jeffrey Stafford, Ph.D. c/o Jecure Therapeutics, Inc. 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Director James Veal, Ph.D. c/o Jecure Therapeutics, Inc. 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Ariel Feldstein, M.D. c/o Jecure Therapeutics, Inc. 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Director Thomas Woiwode, Ph.D. One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director Bradley Bolzon, Ph.D. c/o Jecure Therapeutics, Inc. 3210 Merryfield Row San Diego CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b false 2017-02-13 false true false 0 10025000 10023493 1507 Total Amount Sold includes the conversion of principal and interest under previously outstanding convertible promissory notes. false 4 0 0 0 false Jecure Therapeutics, Inc. /s/ Jeffrey A. Stafford, Ph.D. Jeffrey A. Stafford, Ph.D. Chief Executive Officer 2017-02-17